Literature DB >> 12387283

ACOG Committee Opinion: safety of Lovenox in pregnancy.

.   

Abstract

Lovenox (enoxaparin sodium) therapy appears to be safe and efficacious for pregnant women who are candidates for either prophylactic or therapeutic heparin. However, the use of enoxaparin and other low-molecular-weight heparins for therapeutic anticoagulation is not recommended for pregnant women with prosthetic heart valves. Additionally, enoxaparin should be used with caution or discontinued before administration of epidural for pain relief during labor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387283

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience.

Authors:  Nancy L Shapiro; Michelle A Kominiarek; Edith A Nutescu; Aimee B Chevalier; Judith U Hibbard
Journal:  Pharmacotherapy       Date:  2011-07       Impact factor: 4.705

2.  Intracranial hemorrhage in pregnancy.

Authors:  Afshan B Hameed; Vineet K Shrivastava; Lisa Blair; Deborah A Wing
Journal:  AJP Rep       Date:  2012-06-27

3.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pregnancy in pulmonary hypertension.

Authors:  Javed Khan; Majdy M Idrees
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.